Intranasal Delivery of Umbilical Cord-Derived Mesenchymal Stem Cells Preserves Myelination in Perinatal Brain Damage

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Stem Cells and Development

• Publication date

  2016-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/scd.2016.0027PMID 27392671
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IGF-1/IGF-R Signaling in Traumatic Brain Injury: Impact on Cell Survival, Neurogenesis, and Behavioral Outcome

  2015cited by this paper
• Brain-Derived Neurotrophic Factor Administration Mediated Oligodendrocyte Differentiation and Myelin Formation in Subcortical Ischemic Stroke

  2015cited by this paper
• Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities

  2015cited by this paper
• The role of inflammation in perinatal brain injury

  2015cited by this paper
• Neurotrophic factors and their effects in the treatment of multiple sclerosis

  2015cited by this paper
• Brain Injury in the Preterm Infant: New Horizons for Pathogenesis and Prevention.

  2015cited by this paper
• Development of Cerebral Gray and White Matter Injury and Cerebral Inflammation over Time after Inflammatory Perinatal Asphyxia

  2015cited by this paper
• Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells.

  2015cited by this paper
• The secretome of mesenchymal stromal cells: Role of extracellular vesicles in immunomodulation.

  2015cited by this paper
• MSCs and hyaluronan: sticking together for new therapeutic potential?

  2014cited by this paper
• Oligodendrocyte Pathophysiology and Treatment Strategies in Cerebral Ischemia

  2014cited by this paper
• Stem Cells From Umbilical Cord Wharton’s Jelly From Preterm Birth Have Neuroglial Differentiation Potential

  2013cited by this paper
• Mesenchymal Stem Cells Induce T-Cell Tolerance and Protect the Preterm Brain after Global Hypoxia-Ischemia

  2013cited by this paper
• Digestion products of the PH20 hyaluronidase inhibit remyelination

  2013cited by this paper
• Stem Cell Therapy for Neonatal Diseases Associated with Preterm Birth

  2013cited by this paper
• Intranasal Mesenchymal Stem Cell Treatment for Neonatal Brain Damage: Long-Term Cognitive and Sensorimotor Improvement

  2013cited by this paper
• Laminin regulates postnatal oligodendrocyte production by promoting oligodendrocyte progenitor survival in the subventricular zone

  2012cited by this paper
• Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease

  2011cited by this paper
• Wharton's Jelly stem cells: future clinical applications.

  2011cited by this paper
• Intranasal delivery of stem cells to the brain

  2011cited by this paper
• MSCs guide neurite directional extension and promote oligodendrogenesis in NSCs.

  2009cited by this paper
• Novel Vasoconstrictor Formulation to Enhance Intranasal Targeting of Neuropeptide Therapeutics to the Central Nervous System

  2009cited by this paper
• Adult stem cell therapy for acute brain injury in children.

  2008cited by this paper
• Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury

  2008cited by this paper
• Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.

  2007cited by this paper
• Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation

  2005cited by this paper
• Periventricular leucomalacia: a review

  2004cited by this paper
• New oligodendrocytes are generated after neonatal hypoxic‐ischemic brain injury in rodents

  2004cited by this paper
• Development of a postnatal 3-day-old rat model of mild hypoxic-ischemic brain injury.

  2003cited by this paper
• Selective Cortical Alteration after Hypoxic-Ischemic Injury in the Very Immature Rat Brain

  2003cited by this paper
• Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human.

  2003cited by this paper
• Hypoxic-Ischemic Oligodendroglial Injury in Neonatal Rat Brain

  2002cited by this paper
• Selective Vulnerability of Late Oligodendrocyte Progenitors to Hypoxia–Ischemia

  2002cited by this paper
• Evaluation of the clearance characteristics of bioadhesive systems in humans.

  1999cited by this paper
• Maternal infection and cerebral palsy in infants of normal birth weight.

  1997cited by this paper
• Comparative morphometry of the nasal cavity in rats and mice.

  1982cited by this paper

• Intranasally Delivered Mesenchymal Stem Cells Reverses Prodromal Non-Motor Deficits and Nigral Loss in a Parkinson’s Disease Mouse Model

  2026cites this paper
• Implementation of a novel hybrid cord blood banking model within a private‐public‐partnership

  2025cites this paper
• Research Progress on the Therapeutic Efficacy of Human Umbilical Cord Mesenchymal Stromal Cells for Cerebral Palsy in Children

  2025cites this paper
• Intraperitoneal rescue stem cell therapy in experimental NEC mitigates intestinal, pulmonary, and neuroinflammatory injury in mice.

  2025cites this paper
• Transplanted oligodendrocyte progenitor cells improve neurological defects in a rat model of preterm white-matter injury during the sequela phase

  2025cites this paper
• Modifying the Secretome of Mesenchymal Stem Cells Prolongs the Regenerative Treatment Window for Encephalopathy of Prematurity

  2024cites this paper
• Oligodendrocyte Progenitor Cell Transplantation Reduces White Matter Injury in a Fetal Goat Model

  2024cites this paper
• Role of neuroserpin and N-Cadherin in mesenchymal stromal cell modulation of preterm brain injury.

  2024cites this paper
• Mining human clinical waste as a rich source of stem cells for neural regeneration

  2024cites this paper
• Benefits of bone marrow mesenchymal stem cells compared to their conditioned medium in valproic acid-induced autism in rats

  2024cites this paper
• Gut-Brain cross talk: The pathogenesis of neurodevelopmental impairment in necrotizing enterocolitis

  2023cites this paper
• The Truth Is Out There: Biological Features and Clinical Indications of Extracellular Vesicles from Human Perinatal Stem Cells

  2023cites this paper
• Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood–Brain Barrier (BBB)

  2023cites this paper
• Stem cells as a therapeutic avenue for active and long-term complications of Necrotizing Enterocolitis.

  2023cites this paper
• Extracellular vesicles from immortalized mesenchymal stromal cells protect against neonatal hypoxic-ischemic brain injury

  2023cites this paper
• Stem cell-based interventions for the prevention and treatment of intraventricular haemorrhage and encephalopathy of prematurity in preterm infants.

  2023cites this paper
• Glial Response to Intranasal Mesenchymal Stem Cells in Intermittent Cuprizone Model of Demyelination

  2022cites this paper
• Recent Investigations on Neurotransmitters’ Role in Acute White Matter Injury of Perinatal Glia and Pharmacotherapies—Glia Dynamics in Stem Cell Therapy

  2022cites this paper
• Cell-Based and Gene-Based Therapy Approaches in Neuro-orthopedic Disorders: a Literature Review

  2022cites this paper
• Emerging neuroprotective interventions in periventricular leukomalacia - A systematic review of preclinical studies

  2022influential citation
• Neuroimmune metabolism: Uncovering the role of metabolic reprogramming in central nervous system disease

  2021cites this paper
• Identify the role of Human Wharton's Jelly Mesenchymal Stem Cells in repairing injured uterine of rat

  2021cites this paper
• Feasibility of Umbilical Cord Blood Collection in Neonates at Risk of Brain Damage—A Step Toward Autologous Cell Therapy for a High-risk Population

  2021cites this paper
• Preclinical Safety Evaluation of Intranasally Delivered Human Mesenchymal Stem Cells in Juvenile Mice

  2021cites this paper
• Human Wharton’s Jelly Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Drive Oligodendroglial Maturation by Restraining MAPK/ERK and Notch Signaling Pathways

  2021cites this paper
• Advances in intranasal application of stem cells in the treatment of central nervous system diseases

  2021cites this paper
• Mechanism of White Matter Injury and Promising Therapeutic Strategies of MSCs After Intracerebral Hemorrhage

  2021cites this paper
• siRNA Therapeutics for Protein Misfolding Diseases of the Central Nervous System.

  2021cites this paper
• Exosomes targeted towards applications in regenerative medicine

  2021cites this paper
• ZJU-37 Promoted OPC Survival and Myelination in a Rat Neonatal White Matter Injury Model With hOPC Graft 

  2021cites this paper
• A novel RIP1/RIP3 dual inhibitor promoted OPC survival and myelination in a rat neonatal white matter injury model with hOPC graft

  2021cites this paper
• Preimplantation factor modulates oligodendrocytes by H19-induced demethylation of NCOR2

  2021cites this paper
• Transplanted Human Oligodendrocyte Progenitor Cells Restore Neurobehavioral Deficits in a Rat Model of Preterm White Matter Injury

  2021cites this paper
• Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species

  2020cites this paper
• Three-Dimensional Culture of Umbilical Cord Mesenchymal Stem Cells Effectively Promotes Platelet Recovery in Immune Thrombocytopenia.

  2020cites this paper
• Commentary – Exosomes: Realization of the great therapeutic potential of stem cells

  2020cites this paper
• Mesenchymal stromal cell-derived extracellular vesicles modulate microglia/macrophage polarization and protect the brain against hypoxia-ischemic injury in neonatal mice by targeting delivery of miR-21a-5p.

  2020cites this paper
• Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice

  2020cites this paper
• Preterm Brain Injury, Antenatal Triggers, and Therapeutics: Timing Is Key

  2020cites this paper
• Intranasal mesenchymal stem cell therapy to boost myelination after encephalopathy of prematurity

  2020cites this paper
• Acute symptomatic neonatal seizures, brain injury, and long-term outcome: The role of neuroprotective strategies

  2020cites this paper
• What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?

  2020cites this paper
• Intranasal administration of small extracellular vesicles derived from mesenchymal stem cells ameliorated the experimental autoimmune encephalomyelitis.

  2020cites this paper
• Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury

  2019cites this paper
• Prenatal stem cell therapy for inherited diseases: Past, present, and future treatment strategies

  2019cites this paper
• Stem cell treatment and cerebral palsy: Systemic review and meta-analysis

  2019cites this paper
• Dysmaturation of Premature Brain: Importance, Cellular Mechanisms, and Potential Interventions.

  2019cites this paper
• Neuroprotection in preterm birth by modification of astrocyte polarization

  2019cites this paper
• Synthetic PreImplantation Factor (sPIF) induces posttranslational protein modification and reverses paralysis in EAE mice

  2019cites this paper
• Transfer of mitochondria from mesenchymal stem cells derived from induced pluripotent stem cells attenuates hypoxia-ischemia-induced mitochondrial dysfunction in PC12 cells

  2019cites this paper
• Intranasally Administered Exosomes from Umbilical Cord Stem Cells Have Preventive Neuroprotective Effects and Contribute to Functional Recovery after Perinatal Brain Injury

  2019influential citation
• Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application

  2019cites this paper
• Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients

  2019cites this paper
• Preterm brain Injury: White matter injury.

  2019cites this paper
• The Potential of Stem Cell Therapy to Repair White Matter Injury in Preterm Infants: Lessons Learned From Experimental Models

  2019cites this paper
• Migratory potential of transplanted glial progenitors as critical factor for successful translation of glia replacement therapy: The gap between mice and men

  2018cites this paper
• Bibliometric analysis of global scientific activity on umbilical cord mesenchymal stem cells: a swiftly expanding and shifting focus

  2018cites this paper
• Prospects of Perineural Implantation of Stem Cells in Recovery of Neural Network’s Functions in Brain Diseases

  2018cites this paper
• Encephalopathy of Prematurity: Neuropathology

  2018cites this paper
• Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy

  2018cites this paper
• An update on intracerebral stem cell grafts

  2018cites this paper
• Extracellular Vesicles Derived from Wharton’s Jelly Mesenchymal Stem Cells Prevent and Resolve Programmed Cell Death Mediated by Perinatal Hypoxia-Ischemia in Neuronal Cells

  2018cites this paper
• Prospects of Perineural Administration of Autologous Mesenchymal Stem Cells of Adipose Tissue in Patients with Cerebral Infarction

  2018cites this paper
• Encephalopathy of Prematurity: Clinical-Neurological Features, Diagnosis, Imaging, Prognosis, Therapy

  2018cites this paper
• Wharton's Jelly Mesenchymal Stem Cells Protect the Immature Brain in Rats and Modulate Cell Fate

  2017cites this paper
• A Novel Three-Dimensional Culture System for Oligodendrocyte Precursor Cells

  2017cites this paper
• Rat umbilical cord blood cells attenuate hypoxic–ischemic brain injury in neonatal rats

  2017cites this paper
• OF INTEREST – July , 2016 Recombinant human erythropoietin improves neurological outcomes in very preterm infants

  2016cites this paper